An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.

[1]  V. Abbate,et al.  Advances in the Detection of Growth Hormone Releasing Hormone Synthetic Analogs. , 2021, Drug testing and analysis.

[2]  K. Deventer,et al.  Combining direct urinary injection with automated filtration and nanoflow LC-MS for the confirmatory analysis of doping-relevant small peptide hormones. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  K. Deventer,et al.  Doping control analysis of small peptides: A decade of progress. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  R. Ventura,et al.  Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry. , 2020, Journal of chromatography. A.

[5]  K. Deventer,et al.  A high-throughput assay for the quantification of intact Insulin-Like Growth Factor I in human serum using online SPE-LC-HRMS. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[6]  K. Deventer,et al.  Urinary detection of rapid-acting insulin analogues in healthy humans. , 2020, Drug testing and analysis.

[7]  F. Lanças,et al.  Miniaturized liquid chromatography focusing on analytical columns and mass spectrometry: A review. , 2020, Analytica chimica acta.

[8]  M. Thevis,et al.  Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy , 2019, Clinical chemistry and laboratory medicine.

[9]  E. Deconinck,et al.  Falsification of biotechnology drugs: current dangers and/or future disasters? , 2018, Journal of pharmaceutical and biomedical analysis.

[10]  K. Deventer,et al.  Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500 and GHRP 5. , 2017, Analytical biochemistry.

[11]  M. Thevis,et al.  Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS , 2016, Analytical and Bioanalytical Chemistry.

[12]  J. Namieśnik,et al.  Miniaturized solid-phase extraction techniques , 2015 .

[13]  Steven Ray Wilson,et al.  Nano-LC in proteomics: recent advances and approaches. , 2015, Bioanalysis.

[14]  M. Thevis,et al.  Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. , 2015, Drug testing and analysis.

[15]  K. Deventer,et al.  Identification of the growth hormone-releasing hormone analogue [Pro1, Val14]-hGHRH with an incomplete C-term amidation in a confiscated product. , 2014, Drug testing and analysis.

[16]  Koen Deventer,et al.  Dilute-and-shoot-liquid chromatography-mass spectrometry for urine analysis in doping control and analytical toxicology , 2014 .

[17]  Wilhelm Schänzer,et al.  Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. , 2012, Methods.

[18]  E. Lundanes,et al.  Automatic filtration and filter flush for robust online solid-phase extraction liquid chromatography. , 2011, Journal of separation science.

[19]  M. Thevis,et al.  Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.

[20]  P. Hemmersbach,et al.  Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. , 2010, Drug testing and analysis.

[21]  D. Potvin,et al.  Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension , 2010, Journal of acquired immune deficiency syndromes.

[22]  M. Thevis,et al.  Proteases in Doping Control Analysis , 2007, International journal of sports medicine.

[23]  Wilhelm Schänzer,et al.  Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing. , 2007, Rapid communications in mass spectrometry : RCM.

[24]  D. Bridon,et al.  Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. , 2005, Endocrinology.

[25]  M. Chance,et al.  Secondary reactions and strategies to improve quantitative protein footprinting. , 2005, Analytical chemistry.

[26]  P. Caliceti,et al.  PEGylation of growth hormone-releasing hormone (GRF) analogues. , 2003, Advanced drug delivery reviews.

[27]  M. Karas,et al.  Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: when does ESI turn into nano-ESI? , 2003, Journal of the American Society for Mass Spectrometry.

[28]  J. Veldhuis,et al.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. , 1998, Endocrine reviews.

[29]  C. Cramers,et al.  Microcolumn liquid chromatography: Instrumentation, detection and applications , 1997 .

[30]  J. Jansson,et al.  Growth hormone-releasing hormone. , 1986, Endocrine reviews.

[31]  H. Kaji,et al.  L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. , 1986, The Journal of clinical endocrinology and metabolism.